Almac partners with Exco InTouch

Tuesday, March 22, 2011 11:05 AM

Almac’s Clinical Technologies business unit, a provider of IXRS (Interactive Voice and Web Response) services for patient and drug supply management, has formed an integrated patient management alliance with Exco InTouch, a firm specializing in patient recruitment, retention, compliance and ePRO services. The alliance will focus on the integration of technology and processes by both firms to deliver patient management, compliance, retention and ePRO service offerings to sponsors of clinical trials.

The Almac-Exco InTouch offering serves a need in the drug development process: engaging, retaining and enhancing compliance of patients from the earliest stages of recruitment throughout the course of a trial. Exco InTouch will integrate its retention and compliance technology solutions with Almac’s IXRS technology, an integrated phone and web platform. This will allow patients to receive messages for key elements of their required study conduct using text messages, emails or phone calls. Patients will receive reminders to attend clinic visits or to fill out patient diaries, medication prompts and motivational messages to encourage ongoing participation.

Almac President Jim Murphy said, “The alliance between Almac and Exco InTouch provides sponsors with a practical, cost-effective solution to managing patients during a clinical trial. Our joint solutions will help enhance patient recruitment, retention, and compliance, three highly critical areas of concern for our clients.”

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs